Idexx Laboratories (IDXX) Other Non-Current Assets (2009 - 2026)
Idexx Laboratories (IDXX) posted Other Non-Current Assets of $567.7 million for Q2 2026, up 2.7% on a QoQ basis from $552.8 million in Q1 2026, and down 2.24% year-over-year from $580.8 million in Q2 2025.
Analysis
Idexx Laboratories (IDXX) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Idexx Laboratories has reported Other Non-Current Assets for 18 years, with the latest figure at $567.7 million in Q2 2026.
- On a quarterly basis, Other Non-Current Assets fell 2.24% year-over-year to $567.7 million in Q2 2026; TTM through Jun 2026 was $567.7 million, a 2.24% decrease from a year earlier, with the FY2025 full-year figure at $542.5 million, down 0.92% from the prior year.
- Other Non-Current Assets was $567.7 million for Q2 2026 at Idexx Laboratories, up from $552.8 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $580.8 million in Q2 2025, with the low at $335.6 million in Q1 2022.
- Average Other Non-Current Assets over 5 years is $489.5 million, with a median of $506.2 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets jumped 30.53% in 2022, then declined 8.17% in 2025.
- Over 5 years, Other Non-Current Assets stood at $417.7 million in 2022, then advanced by 18.87% to $496.5 million in 2023, then rose by 10.27% to $547.5 million in 2024, then dropped by 0.92% to $542.5 million in 2025, then advanced by 4.65% to $567.7 million in 2026.
- The last three Other Non-Current Assets figures came in at $567.7 million (Q2 2026), $552.8 million (Q1 2026), and $542.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 567.73 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 384.00 Mn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 304.00 Mn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 106.46 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 31,658.00 |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | 988,922.10 |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 567.73 Mn |
| Mar 31, 2026 | 552.79 Mn |
| Dec 31, 2025 | 542.48 Mn |
| Sep 30, 2025 | 513.57 Mn |
| Jun 30, 2025 | 580.77 Mn |
| Mar 31, 2025 | 547.56 Mn |
| Dec 31, 2024 | 547.52 Mn |
| Sep 30, 2024 | 559.27 Mn |
| Jun 30, 2024 | 539.72 Mn |
| Mar 31, 2024 | 498.91 Mn |
| Dec 31, 2023 | 496.53 Mn |
| Sep 30, 2023 | 448.40 Mn |
| Jun 30, 2023 | 439.23 Mn |
| Mar 31, 2023 | 421.15 Mn |
| Dec 31, 2022 | 417.73 Mn |
| Sep 30, 2022 | 403.44 Mn |
| Jun 30, 2022 | 398.55 Mn |
| Mar 31, 2022 | 335.57 Mn |
| Dec 31, 2021 | 330.40 Mn |
| Sep 30, 2021 | 317.14 Mn |